Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Hallinen · SciRah

Researcher profile · Semantic Scholar

T. Hallinen

Share profile

T. Hallinen — researcher profile on SciRah

h-index: 14
Works: 42
Citations: 508

Most-cited papers

Cost–utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting
T. Hallinen, E. Soini, K. Eklund, K. Puolakka
2010Rheumatology55 citations Open access
Semantic Scholar
Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis
E. Soini, T. Hallinen, K. Puolakka, V. Vihervaara +1 more
2012Journal of Medical Economics52 citations Open access
Semantic Scholar
Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)
A. Eberl, T. Hallinen, C. Af Björkesten, M. Heikkinen +16 more
2019Scandinavian Journal of Gastroenterology46 citations Open access
Semantic Scholar
Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men
P. Peura, J. Martikainen, E. Soini, T. Hallinen +1 more
2008Current Medical Research and Opinion34 citations
Semantic Scholar
Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme
J. Martikainen, A. Kivioja, T. Hallinen, P. Vihinen
2012PharmacoEconomics (Auckland)26 citations
Semantic Scholar
Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data
T. Hallinen, E. Soini, C. Asseburg, Pekka Kuosmanen +1 more
2014BMJ Open24 citations Open access
Semantic Scholar
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
E. Soini, T. Hallinen, M. Brignone, R. Campbell +6 more
2017Expert review of pharmacoeconomics & outcomes research23 citations
Semantic Scholar
Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting
T. Hallinen, J. Martikainen, E. Soini, L. Suominen +1 more
2006Current Medical Research and Opinion23 citations
Semantic Scholar
Price-cost margin in the pharmaceutical industry
I. Linnosmaa, Raine Hermans, T. Hallinen
2004The European Journal of Health Economics, formerly: HEPAC22 citations
Semantic Scholar
Administration costs of intravenous biologic drugs for rheumatoid arthritis
E. Soini, M. Leussu, T. Hallinen
2013SpringerPlus20 citations Open access
Semantic Scholar
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis
T. Mälkönen, P. Nuutinen, T. Hallinen, E. Soini +18 more
2021Acta Dermato-Venereologica19 citations Open access
Semantic Scholar
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort
C. Af Björkesten, T. Ilus, T. Hallinen, E. Soini +20 more
2020European Journal of Gastroenterology and Hepathology17 citations Open access
Semantic Scholar
Costs and quality of life effects of the first year of renal replacement therapy in one Finnish treatment centre
T. Hallinen, E. Soini, J. Martikainen, R. Ikäheimo +1 more
2009Journal of Medical Economics17 citations
Semantic Scholar
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
T. Hallinen, E. Soini, C. Asseburg, M. Linna +3 more
2021ClinicoEconomics and Outcomes Research15 citations Open access
Semantic Scholar
Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management
E. Soini, O. Riekkinen, H. Kröger, P. Mankinen +2 more
2018ClinicoEconomics and Outcomes Research14 citations Open access
Semantic Scholar
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
T. Hallinen, Santtu Kivelä, E. Soini, V. Harjola +1 more
2023ClinicoEconomics and Outcomes Research13 citations Open access
Semantic Scholar
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland
T. Sipponen, C. Af Björkesten, T. Hallinen, T. Ilus +13 more
2021Scandinavian Journal of Gastroenterology13 citations Open access
Semantic Scholar
Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders
T. Hallinen, E. Soini, O. Granström, Yrjö Ovaskainen +3 more
2012BMJ Open11 citations Open access
Semantic Scholar
The Impact of the Pharmaceutical Pricing System on Cost-Effectiveness Results: Finnish Analysis
T. Hallinen, E. Soini
201111 citations Open access
Semantic Scholar
Price-cost margin in the pharmaceutical industry. Empirical evidence from Finland.
I. Linnosmaa, Raine Hermans, T. Hallinen
2004The European journal of health economics : HEPAC : health economics in prevention and care10 citations
Semantic Scholar
Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients
T. Hallinen, E. Soini, M. Linna, S. Saarni
2016SpringerPlus9 citations Open access
Semantic Scholar
Efficient Secondary Use of Representative Social and Health Care Data In Finland: Isaacus Data Lake, Analytics and Knowledge Management Pre-Production Project
E. Soini, T. Hallinen, A. Kekoni, J. Kotimaa +3 more
20175 citations Open access
Semantic Scholar
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study
P. Molander, C. Af Björkesten, H. Henricson, R. Koskela +15 more
2025European Journal of Gastroenterology and Hepathology4 citations Open access
Semantic Scholar
PCP43 - HEALTH IMPACT MODELLING (HIM): CONCEPT, APPROACH AND REAL-WORLD DATA NEEDS FOR THE ESTIMATION OF POTENTIAL EFFECTIVENESS PROVIDED BY A PHARMA COMPANY PORTFOLIO
E. Soini, T. Hallinen, J. Laine
2018Value in Health4 citations Open access
Semantic Scholar
Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
E. Soini, T. Hallinen, A. Sokka, K. Saarinen
2015Advances in Therapy4 citations Open access
Semantic Scholar
Cost-effectiveness of insulin glargine compared to other long-acting basal insulins in the treatment of Finnish type 1 and type 2 diabetes patients based on individual studies
T. Hallinen, E. Soini, C. Asseburg, R. Suominen +1 more
20124 citations
Semantic Scholar
PMH45 COST-UTILITY OF AGOMELATINE, VENLAFAXINE AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN FINLAND—ECONOMIC MODELLING STUDY USING REPRESENTATIVE POPULATION DATA
E. Soini, T. Hallinen
20094 citations Open access
Semantic Scholar
RWD63 Comparison of Certified Secure Processing Environments (SPE) – Novel Platforms for Collection, Augmentation, Structuring, Transfer, Management, Analysis, Sharing, Reporting, and Storage of Sensitive Data?
E. Soini, T. Hallinen, J. Martikainen
2022Value in Health1 citations Open access
Semantic Scholar
RWD31 Secure Processing Environments (SPE) Are Needed for the Cybersecure Collection and Secondary Use of Personal, Health, and Social Data
E. Soini, T. Hallinen, J. Martikainen
2022Value in Health1 citations Open access
Semantic Scholar
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
T. Hallinen, E. Soini, C. Asseburg, M. Linna +3 more
20211 citations
Semantic Scholar
P224 Relationship of faecal calprotectin and long-term outcomes in Finnish adult patients with Crohn’s disease: Retrospective multi-centre chart review study
T. Hallinen, A. Jussila, C. Af Björkesten, H. Kemppainen +6 more
20181 citations
Semantic Scholar
Original article Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis
E. Soini, T. Hallinen, K. Puolakka, V. Vihervaara +2 more
20121 citations
Semantic Scholar
PMH68 Differential Use of Extended and Instant Release Quetiapine: A Naturalistic Study of Finnish Inpatients with Schizophrenia Spectrum or Bipolar Disorders
T. Hallinen, E. Soini, O. Granström, Yrjö Ovaskainen +3 more
20111 citations Open access
Semantic Scholar
BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND
E. Soini, T. Hallinen, M. Taiha, V. Honkanen
20101 citations Open access
Semantic Scholar
PR3 THE IMPACT OF FINNISH PHARMACEUTICAL PRICING SCHEME IN COST-EFFECTIVENESS ANALYSES
T. Hallinen, E. Soini
20101 citations Open access
Semantic Scholar
PRS5 REDUCTION IN TOTAL TREATMENT COSTS THROUGH IMPROVED PHARMACEUTICAL TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
T. Hallinen, J. Karjalainen, J. Hahl, S. Torvinen +1 more
20071 citations Open access
Semantic Scholar
PIH28 - ISAACUS DATA LAKE PRE-PRODUCTION PROJECT: CHILD PLACEMENT DECISION AND ITS COST DRIVERS
T. Hallinen, E. Soini, J. Tirkkonen, A. Kekoni
2018Value in Health0 citations Open access
Semantic Scholar
Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data
E. Soini, T. Hallinen, V. Vihervaara, M. Kauppi
20130 citations Open access
Semantic Scholar
Dabigatraanin kustannusvaikuttavuus eteisvärinäpotilaiden aivohalvausten ehkäisyssä
T. Hallinen, E. Soini, Mikko Tuovinen
20120 citations
Semantic Scholar
PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES
E. Soini, T. Hallinen, M. Kauppi, V. Vihervaara +1 more
20100 citations Open access
Semantic Scholar
PMS58 COST-UTILITY ANALYSIS OF DIFFERENT TREATMENT STRATEGIES AFTER THE FAILURE OF FIRST BIOLOGIC TREATMENT IN RHEUMATOID ARTHRITIS (RA) IN THE FINNISH SETTING
T. Hallinen, E. Soini, K. Eklund, K. Puolakka
20090 citations Open access
Semantic Scholar
PHM5 ADVATE IS COST-EFFECTIVE INVESTMENT IN HEMOPHILIA A TREATMENT WHEN PATHOGENS EMERGE—A SCENARIO-BASED ECONOMIC AND POSITIVE INVESTMENT INTERVAL (Pll) EVALUATION
E. Soini, T. Hallinen, A. Sirkka
20070 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Soini×31
Invite
E. Soini — researcher profile on SciRah
E. Soini×6
Invite
E. Soini — researcher profile on SciRah
K. Puolakka×5
Invite
K. Puolakka — researcher profile on SciRah
C. Af Björkesten×5
Invite
C. Af Björkesten — researcher profile on SciRah

×5

Invite

J. Martikainen — researcher profile on SciRah

V. Vihervaara×4

Invite

V. Vihervaara — researcher profile on SciRah

Invite

M. Kauppi — researcher profile on SciRah

Invite

H. Nuutinen — researcher profile on SciRah

Ulla-Maija Suhonen×4

Invite

Ulla-Maija Suhonen — researcher profile on SciRah

Invite

R. Nissinen — researcher profile on SciRah

Invite

M. Koivunen — researcher profile on SciRah

Invite

J. Tillonen — researcher profile on SciRah